BackAcceleron Pharma Overview

Acceleron Pharma Profit Margin

Profitability ratio analysis for XLRN.

Quarterly Profit Margin

-206.04%
↓ 18.45% YoY

As of Sep 2021

Annual Profit Margin (TTM)

-226.01%
↓ 81.20% YoY

Trailing 12 months ending Sep 2021

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin